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Recruitment of leukocytes from the bloodstream to inflamed tissues requires a carefully
regulated cascade of binding interactions between adhesion molecules on leukocytes and
endothelial cells. Adhesive interactions between CD44 and hyaluronan (HA) have been
implicated in the regulation of immune cell trafficking within various tissues. In this review,
the biology of CD44–HA interactions in cell trafficking is summarized, with special attention
to neutrophil recruitment within the liver microcirculation.We describe the molecular mech-
anisms that regulate adhesion between neutrophil CD44 and endothelial HA, including
recent evidence implicating serum-derived hyaluronan-associated protein as an important
co-factor in the binding of HA to CD44 under flow conditions. CD44–HA-mediated neu-
trophil recruitment has been shown to contribute to innate immune responses to invading
microbes, as well as to the pathogenesis of many inflammatory diseases, including vari-
ous liver pathologies. As a result, blockade of neutrophil recruitment by targeting CD44–HA
interactions has proven beneficial as an anti-inflammatory treatment strategy in a number
of animal models of inflammatory diseases.
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INTRODUCTION
The transit of leukocytes from the bloodstream into inflamed tis-
sues involves a series of sequential events, each mediated by the
engagement of adhesion molecules on leukocytes and their ligands
on vascular endothelium. First, cells flowing in the bloodstream
tether to the vessel wall, and begin rolling along the luminal sur-
face. Recent advances in live-cell imaging have revealed that rolling
cells form surface appendages called “long tethers” and “slings”
that stabilize the rolling phase to enable this dynamic cell–cell
interaction to occur at high shear stress (1, 2). Subsequently, cells
firmly adhere to the vascular endothelium, and begin crawling
along the vessel wall until they arrive at a favorable site for trans-
endothelial migration out of the vasculature (3). Upon arrival
within the inflamed tissue, leukocytes are guided by gradients of
chemoattractants to shepherd them toward their final target where
they carry out their effector functions (4).
Each phase of the multi-step cascade of leukocyte recruit-
ment involves binding interactions between adhesion molecules
on leukocytes and their ligands on endothelium. Selectins and
selectin ligands are the prototypic adhesion molecules that medi-
ate tethering and rolling, through their ability to form transient
adhesive “catch” bonds at high shear stress (5). Firm adhesion is
classically ascribed to binding between integrins on immune cells
(Mac-1,LFA-1,VLA-4,etc.) and receptors of the immunoglobulin-
superfamily on endothelium (ICAM-1, VCAM-1, etc.). The ability
of leukocytes such as neutrophils to locomote across the lumi-
nal surface of blood vessels via intra-luminal crawling has also
been shown to involve integrins, while transmigration requires the
coordinated interplay of multiple molecular binding partners (6).
An explosion of research in the field of leukocyte trafficking
in the past 25 years has identified many additional “non-classical”
adhesion molecules that can support cell recruitment in the myr-
iad of cell, organ, and disease-specific contexts that are required
for a functional immune system (7). Among these, CD44 and
its ligand, hyaluronan (HA), have emerged as important adhe-
sion molecules required for cell trafficking in multiple organs, and
contribute to the pathogenesis of a variety of inflammatory dis-
eases. CD44 is a type I transmembrane glycoprotein expressed
by multiple hematopoietic and non-hematopoietic cells. CD44 is
encoded by a single gene, but can be expressed in over 20 iso-
forms as a result of alternative splicing, and can undergo an array
of post-translational modifications, enabling nuanced regulation
and diverse functions. The key ligand for CD44, HA, is a member
of the glycosaminoglycan family of extracellular matrix molecules,
formed from a basic structural unit of repeating dissacharides of
N -acetylglucosamine and N -glucuronic acid. HA is a nearly ubiq-
uitous component of the extracellular matrix, and can be produced
by multiple cell types, including endothelium [for a comprehen-
sive review of the regulation of HA synthesis and metabolism, see
Ref. (8)]. Below, we review the biology of CD44–HA interactions
in immune cell trafficking, explore the molecular mechanisms that
regulate the binding between these molecules, and highlight the
critical role of CD44–HA-mediated leukocyte recruitment in the
pathogenesis of inflammatory diseases.
CD44 AND HYALURONAN IN THE LEUKOCYTE RECRUITMENT
CASCADE
ROLLING
Seminal experiments using a parallel-plate flow-chamber system
to simulate the hemodynamic environment of post-capillary
venules were the first to demonstrate a role for CD44 and HA
in leukocyte trafficking. Lymphocytes were observed to roll on
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HA-coated plates, and this rolling could be inhibited by incubating
the lymphocytes with a function-blocking antibody against CD44
(9). Subsequently, similar in vitro systems were used to demon-
strate that CD44 on lymphocytes could support rolling on a mono-
layer of cultured endothelial cells in an HA-dependent manner (9,
10). These findings were confirmed in vivo in a model of peritoni-
tis, in which T-cells utilized CD44–HA interactions to home to
the inflamed peritoneal cavity (10). Recruitment of superantigen-
activated T-cells into the inflamed peritoneum could be inhibited
by CD44-blocking antibodies, as well as intravenous infusion of
hyaluronidase to degrade endothelial HA (10). However, unlike
lymphocytes, neutrophils are unable to roll on a purified HA sub-
strate in vitro, and neutrophil rolling on cultured endothelial cells
as well as the endothelium of post-capillary venules in vivo is not
dependent on CD44–HA interactions.
In addition, CD44 can also contribute to leukocyte rolling
through interactions with non-HA ligands. Teder and colleagues
identified CD44 as a novel E-selectin ligand, and showed that
binding between these molecules can support neutrophil rolling
in mice and humans (11). Specifically, engagement between neu-
trophil CD44 and endothelial E-selectin was required for slow
rolling, whereas P-selectin-PSGL-1 interactions were required for
initial tethering and fast rolling. Furthermore, neutrophil CD44
from patients with leukocyte adhesion deficiency (LAD) syndrome
type II (due to mutations of the GDP-fucose transporter gene,
resulting in complete deficiency of fucosylated selectin-ligand
moieties) was unable to bind E-selectin, implicating CD44–E-
selectin interactions in the pathogenesis of this disease (11).
In addition to neutrophils, T-lymphocytes also utilize CD44–E-
selectin interactions for slow rolling in vivo, in a manner that is
independent of the contribution of CD44–HA interactions (12).
FIRM ADHESION
Intravital microscopy of the inflamed cremaster muscle of mice
has revealed that unlike rolling, firm adhesion of neutrophils can
be supported by interactions between CD44 and HA. Blocking
antibodies against CD44, genetic deletion of CD44, and removal of
HA from the vascular endothelium have each been shown to atten-
uate neutrophil adhesion (but not rolling), within post-capillary
venules (13). Similarly, as described below, CD44 can support neu-
trophil adhesion within low-shear microvascular beds such as the
liver sinusoids, in which neutrophils undergo primary adhesion
without a pre-requisite rolling step (14).
A role for CD44 in mediating firm adhesion of lymphocytes
has been suggested, but the exact functional contribution of CD44
is less clear. Both in vitro and in vivo, disruption of CD44–
HA interactions limits the adhesion of activated lymphocytes
to endothelium (10, 15). However, given that CD44–HA bind-
ing also mediates the pre-requisite rolling step, the reduction
of firm adhesion may be a secondary effect. This question has
been addressed directly by Nandi and colleagues, who investigated
the contribution of CD44 versus integrins (the prototypic mole-
cules supporting firm adhesion) to adhesion of activated T-cells
to endothelium under flow conditions (16). Interestingly, it was
found that CD44 was required for firm adhesion, although not
through binding interactions with HA. Co-immunoprecipitation
experiments revealed bi-molecular complex formation between
CD44 (which supports rolling) and the integrin VLA-4 (which
supports adhesion) (16). Expression of truncated forms of CD44
that lacked the cytoplasmic tail prevented physical coupling of
CD44 with VLA-4, resulting in cells that could roll (using CD44)
but were unable to adhere. These experiments revealed that while
CD44–HA interactions support lymphocyte rolling, CD44 is also
required for adhesion by directly collaborating with integrins to
enable the formation of high affinity binding to VCAM-1.
TRANS-ENDOTHELIAL MIGRATION AND CHEMOTAXIS
Conflicting data exist regarding the function of CD44 and HA in
trans-endothelial migration and chemotaxis through interstitial
tissues. With respect to transmigration, neutrophil transit across
epithelial monolayers in vitro was found to be attenuated when
neutrophil CD44 was activated, but was unaffected by functional
blockade of the HA-binding domain (17). Importantly, these
experiments tested neutrophil migration across intestinal epithe-
lial monolayers under static conditions, and therefore their applic-
ability to trans-endothelial migration under flow is unknown. In
contrast, visualization of neutrophil recruitment in vivo within
the inflamed cremaster muscle of mice demonstrated reduced
transmigration in CD44 knockout animals (13). The molecu-
lar mechanism by which CD44 contributes to trans-endothelial
migration has not been studied. Similarly, the role of CD44–HA
interaction in chemotaxis is incompletely understood. Khan et al.
found conflicting results between the ability of CD44-deficient
neutrophils to migrate toward chemoattractants in vivo versus
in vitro (13). In an under-agarose migration assay, neutrophils
from CD44-deficient mice had markedly impaired migration
toward MIP-2/CXCL2 compared to wild-type neutrophils. How-
ever, neutrophil chemotaxis within cremaster muscle in vivo was
independent of CD44–HA interactions. The differences observed
between in vitro and in vivo conditions is similar to that observed
for the role of integrins in neutrophil chemotaxis, and may be the
result of differences in the matrix composition through which cells
must migrate in the various models (18, 19). Overall, these studies
reveal a paucity of data on the contribution of CD44–HA interac-
tions to the final phases of leukocyte recruitment, and highlight a
need for further research in this area.
CD44–HA-MEDIATED LEUKOCYTE RECRUITMENT IN
INFLAMMATORY DISEASE
Numerous studies have confirmed the importance of CD44 and
HA in leukocyte recruitment within a variety of organs in vivo.
Antibody blockade of CD44, CD44 deficiency, or enzymatic deple-
tion of endothelial HA (by administration of hyaluronidase) have
been shown to decrease neutrophil, monocyte, and/or lymphocyte
recruitment and attenuate disease activity in models of arthritis
(20, 21), dermatitis (22), peritonitis (10), myositis (13), experi-
mental autoimmune encephalomyelitis (23), orchitis (24), retini-
tis (25), allergic asthma (26), and graft-versus-host disease (27).
However, perhaps one of the best-characterized roles for CD44–
HA interactions in pathological leukocyte recruitment is seen in
inflammatory liver disease.
The liver vasculature represents a unique structural and hemo-
dynamic environment for leukocyte recruitment, as the majority
of infiltrating cells are recruited within the dense labyrinth of
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low-flow, low-shear sinusoids. As a result, the mechanisms of
leukocyte trafficking within these vessels deviate from the clas-
sic multi-step paradigm, in that recruitment does not require a
rolling phase (28). Instead, cells are observed to undergo primary
adhesion within these low-flow vessels. Therefore, the pleiotropic
abilities of CD44–HA interactions to support all steps from teth-
ering to firm adhesion make this binding interaction well suited
to the biology of the liver sinusoids. Furthermore, multiple stud-
ies using a variety of imaging techniques have demonstrated that
the luminal surface of liver sinusoidal endothelium is densely
coated with HA (14, 29, 30). Unlike other vascular beds, in which
endothelial cell CD44 is required to anchor HA to the vessel
wall, liver sinusoidal endothelial cells (LSEC) do not use CD44
to anchor HA, but instead express a variety of scavenger recep-
tors that capture circulating HA on the cell surface, and present
it to passing leukocytes before finally promoting its endocyto-
sis and clearance from the bloodstream (31–33). However, no
studies to date have investigated the functional role of these
scavenger receptors in leukocyte adhesion to HA within liver
sinusoids.
A prominent role for CD44–HA interactions in immune cell
recruitment to the liver was first observed in a model of acute
hepatic inflammation due to sepsis/endotoxemia. Direct visual-
ization of neutrophil trafficking within liver sinusoids revealed
that blockade of CD44–HA interactions led to a 50–70% reduc-
tion in the number of adherent neutrophils (14). While CD44
can engage with other ligands to support leukocyte–endothelial
interactions within other vascular beds (E-selectin and VLA-4, as
described above), this promiscuous activity is not observed in liver
sinusoids, as multiple studies have confirmed that selectins and
α4-integrins do not contribute to neutrophil recruitment within
the liver (14, 28, 34). Menezes and colleagues performed a more
in-depth functional analysis of CD44–HA interaction using con-
focal intravital microscopy in mouse models of endotoxemia and
Gram-negative bacterial sepsis (35). It was found that in addi-
tion to mediating initial adhesion, CD44 was also required for
subsequent stages of recruitment including cell spreading and the
initiation of intravascular crawling.
Subsequently, the role of CD44–HA interactions in cell recruit-
ment to the liver has been observed for other cell types in a variety
of inflammatory contexts. First, Shi et al. revealed that mono-
cyte recruitment to foci of Listeria monocytogenes infection in
the liver was reduced by more than 50% by anti-CD44 antibody
treatment (36). Interestingly, this study observed a roughly equiv-
alent reduction in monocyte infiltration when Mac-1–ICAM-1
interactions were blocked, but it is not known how each receptor–
ligand pair contributes to cell recruitment. One possibility is
that CD44 and Mac-1 function cooperatively to promote initial
monocyte adhesion. Alternatively, these molecules may function
in a sequential manner, with CD44 mediating initial tethering
and adhesion, while Mac-1 supports subsequent intravascular
crawling toward the bacterial targets. Similar to monocytes and
neutrophils, an important role for CD44–HA interactions has
also been observed in cytotoxic T-lymphocyte (CTL) recruit-
ment to the inflamed liver in a mouse model of viral hepatitis
(37). Hepatitis B transgenic mice develop substantial lympho-
cytic inflammatory infiltrates within the liver, whereas transgenic
mice that are also CD44 deficient have markedly attenuated CTL
recruitment. Interestingly, adoptive transfer experiments revealed
that CD44 was required on endothelium, but not on CTLs. This
stands in stark contrast to the role of CD44 in neutrophil and
monocyte recruitment, in which CD44 is required on leukocytes
but not endothelium (14, 36). The mechanism underlying this
observation is not known, but possible explanations include inter-
actions with non-HA ligands on CTLs, or possibly a role for CD44
in upstream inflammatory signaling rather than as an adhesion
molecule in CTL trafficking.
A number of recent studies have described a critical role for
CD44–HA interactions in the pathogenesis of fatty-liver disease,
the leading cause of chronic liver disease in United States and
a growing problem worldwide (38). CD44-deficient mice have
markedly attenuated hepatitis in a mouse model of non-alcoholic
steatohepatitis (NASH), induced by administration of a litho-
genic diet (39, 40). Leukocytes harvested from lithogenic diet-fed
mice display significant upregulation of their HA-binding capac-
ity (39). This correlated with diminished leukocyte infiltration
into the livers of CD44-deficient animals. Using a similar model
of lithogenic diet-induced hepatic steatosis, Kang et al. observed
that CD44-deficient mice displayed reduced leukocyte infiltration
into the liver, in addition to broader defects in steatosis devel-
opment, adipose tissue inflammation, and insulin resistance (40).
Therefore, in addition to supporting leukocyte infiltration into the
liver and the development of NASH, CD44 may be a keystone to
the systemic pathogenesis of obesity-associated diseases and the
metabolic syndrome.
Lastly, CD44–HA interactions have been implicated in the traf-
ficking of hematopoietic stem cells (HSC) to the liver. In vitro
experiments studying adhesive interactions between HSC and cul-
tured LSEC found that binding was partially dependent on CD44–
HA interactions (41). Similarly, CD44 blockade reduced adhesion
of HSC to frozen liver sections from patients with primary biliary
cirrhosis and alcoholic liver disease (41). While these findings await
confirmation in vivo, a similar role for CD44–HA interactions has
been observed in mesenchymal stem cell recruitment to the kid-
ney in an animal model of acute tubular necrosis (42). Together,
these findings suggest that CD44–HA interaction are important
not only for the generation of inflammatory responses, but may
also be critical to the resolution phase and tissue regeneration by
facilitating stem cell homing to injured tissues. This would add an
additional role to the growing list of contributions made by CD44
to the resolution of inflammatory responses (43).
REGULATION OF CD44–HA INTERACTIONS IN CELL
TRAFFICKING
Despite the fact that CD44 is constitutively expressed on most
leukocytes, and HA is a ubiquitous component of the extracellular
matrix, trafficking leukocytes only adhere to HA under inflamma-
tory conditions (44). Engagement between CD44 and HA can be
regulated at a number of levels including the quantity of surface
expression, as well as their functional states of activation.
REGULATION OF CD44 FUNCTION
CD44 expression on the surface of leukocytes can be upregulated
in response to a variety of stimuli including antigen receptor
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cross-linking, mitogens, cytokines, chemokines, and bacterial
products (44). Numerous studies have demonstrated that upreg-
ulation of CD44 expression can lead to augmented recruitment
of various leukocyte subsets to sites of inflammation. Conversely,
defects that result in impaired CD44 surface expression can result
in attenuation of leukocyte trafficking kinetics. For example,
neutrophils from Rab27a-deficient mice display reduced surface
expression of CD44, and as such were found to have impaired
adhesion within liver sinusoids in response to endotoxemia (45).
Although the precise pathway through which Rab27a controls
CD44 expression is not fully elucidated, in vitro observations sug-
gest that this molecule may regulate the intracellular trafficking
and surface presentation of CD44 on the plasma membrane within
neutrophils. Interestingly, genetic defects in the Rab27a gene in
humans results in a rare immunodeficiency syndrome (Griscelli
syndrome 2) characterized by defective neutrophil, NK cell, and
CTL function (46). Given the defects in CD44 expression on neu-
trophils observed in Rab27a-deficient mice, it will be of interest in
future studies to determine if the impairments in CTLs and NK
cells are also linked to defective CD44 expression and function.
It is not only the absolute quantity of CD44 expression on
the cell surface that regulates binding to HA but also the relative
expression compared to other adhesion molecules. Studies of neu-
trophil adhesion in the liver have revealed that the balance between
CD44 and integrin (Mac-1) expression can dramatically alter the
role of CD44 in leukocyte recruitment. Menezes and colleagues
found that CD44–HA interactions are the dominant mechanisms
of adhesion in response to endotoxemia/sepsis, whereas CD44 is
dispensable when hepatic inflammation was induced by a single
neutrophil chemoattractant (fMLP), wherein adhesion required
Mac-1 (35). Analysis of surface expression levels revealed equiv-
alent quantities of CD44 expression regardless of the stimulus,
whereas Mac-1 expression was significantly reduced during endo-
toxemia as a consequence of high circulating IL-10. The authors
postulated that during endotoxemia, downregulation of Mac-1
allows for CD44 to dominate, resulting in preferential adhesion via
CD44–HA interactions, highlighting the functional importance
of relative CD44 expression levels in the control of neutrophil
trafficking.
In addition to regulation of surface expression levels, activa-
tion of leukocytes can also induce a multitude of post-translational
modifications (phosphorylation, glycosylation, sulfation, and oth-
ers) that yield a structurally activated, HA-avid form of CD44
[reviewed by Puré and Cuff (44)]. The functional significance
of such post-translational modifications has been demonstrated
in vitro using flow-chamber experiments, in which lymphocyte
activation, and the resultant modifications of CD44, are required
to enable rolling and adhesion upon HA-coated coverslips (47).
Similarly, activated lymphocytes that are recovered from inflamed
tissues in vivo posses functionally activated forms of CD44, and
demonstrate enhanced binding to HA compared to naïve lympho-
cytes (10, 15). Perhaps the most direct evidence for conformational
activation of CD44 in the control of CD44–HA interaction comes
from studies using the IRAWB14.4 antibody, which binds CD44
and alters its conformation directly to generate high HA-avidity.
As a result, this antibody commonly serves as a positive control in
HA-binding experiments (14, 15).
REGULATION OF HA FUNCTION
While expression and activation of leukocyte CD44 are clearly
important for the regulation of cell trafficking, there is emerg-
ing evidence that leukocyte recruitment is also modulated by
changes in HA expression and/or function at the level of vascular
endothelium. First, endothelial cells have the ability to augment
their surface expression of HA under inflammatory conditions.
Using cultured endothelial cell lines as well as primary endothelial
cells, Siegelman and colleagues found that stimulation with TNFα,
IL-1β, or LPS resulted in upregulated surface expression of HA
(48). Interestingly, this phenotype was only observed in endothe-
lial cells derived from microvascular beds (but not larger vessels)
in which the majority of leukocyte recruitment occurs (48). Using
a parallel-plate flow-chamber assay, the authors confirmed that
CD44-dependent lymphocyte rolling was increased fourfold upon
activated endothelial monolayers as a result of upregulated surface
expression of HA (48).
In addition to quantitative regulation of HA expression, leuko-
cyte trafficking can also be modulated by functional changes to the
structure of HA polymers. First, HA polymer length has received
a great deal of attention in recent years as an important rheostatat
for the inflammatory response, as a result of its multi-functional
inflammatory/anti-inflammatory signaling properties mediated
by low versus high molecular weight HA (49). Polymer length
may also regulate the function of HA as an adhesion molecule,
as evidenced by the fact that digestion with hyaluronidase impairs
leukocyte–endothelial interactions. In addition, a growing body of
research suggests that a major regulator of HA–CD44 interactions
involves structural modification of HA induced by a variety of
HA-binding proteins. Serum-derived hyaluronan-associated pro-
teins (SHAPs), is an HA-binding protein that has been shown
to modulate leukocyte trafficking through functional alterations
of the adhesion properties of HA. Structurally, SHAP is com-
posed of the heavy chains (HC) of inter-α-trypsin inhibitor, a
circulating proteoglycan consisting of a single chondroitin sul-
fate molecule bound to bikunin (a serine protease inhibitor)
and the aforementioned HC (HC1, HC2, HC3) (50). At sites of
inflammation, IαI HC (SHAP) are transferred onto HA through
a trans-esterification reaction catalyzed by tumor necrosis factor-
stimulated gene 6 (TSG-6), yielding a covalently bound SHAP–HA
complex (50). SHAP–HA complexes purified from the synovial
fluid of patients with rheumatoid arthritis bind with greater avid-
ity to lymphocyte CD44 than native HA alone (51). Furthermore,
lymphocyte rolling and adhesion in vitro upon a substratum of
SHAP–HA is increased more than fourfold compared to HA alone
(51). Some studies have suggested that SHAP–HA complexes may
enable adhesion regardless of the activation state of leukocyte
CD44 (52). Systematic inhibition studies have confirmed that
adhesion to SHAP–HA still occurs exclusively between HA and
CD44, and that the role of SHAP is indirect through functional
alterations of HA macromolecular structure (51). Immunoflu-
orescence imaging has revealed that binding of SHAP induces
profound architectural changes to the macro-structure of HA
polymers, resulting in coalescence of HA polymers into multi-cell-
length cables (52). This concentration of HA polymers may aug-
ment binding to leukocytes by enabling high avidity interactions
with leukocyte CD44, potentially providing favorable clustering
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of CD44 within plasma membrane microdomains. Alternatively,
formation of SHAP–HA complexes may protect HA from degra-
dation or endocytosis, thereby stabilizing the surface landscape
of the vascular endothelium to promote interactions with passing
leukocytes.
Serum-derived hyaluronan-associated protein–HA complexes
are observed in multiple inflamed organs. High concentrations
have been demonstrated in the synovial fluid of patients with
rheumatoid arthritis (51), and colon tissue from patients with
active inflammatory bowel disease (52). Within the colon of
patients with IBD, SHAP–HA complexes were observed primarily
around blood vessels, as well as within the hyperplastic muscularis
layer (52). Within the liver microvasculature, neutrophil adhesion
in response to bacterial LPS is preceded by marked induction of
SHAP–HA complex formation on the endothelial surface (14, 53).
Unlike HA, which is present in liver sinusoids constitutively at high
levels, SHAP–HA complexes are only seen after exposure to bac-
terial products or other stimuli, and CD44-bearing neutrophils
adhere within regions that are richly decorated with SHAP–HA
complexes (14, 54). Experiments in mice that lack the SHAP pre-
cursor (IαI), and are therefore SHAP-deficient, have revealed that
neutrophil adhesion is reduced by ~50% compared to wild-type
animals (53). Together, these studies implicate functional “activa-
tion” of HA in response to SHAP (and perhaps other HA-binding
proteins) in the regulation of leukocyte adhesion. Further studies
are needed to clarify the mechanisms responsible for the enhanced
avidity of HA for CD44 following binding by SHAP, and whether
the macro-structural alteration (such as cable formation) that are
seen in vitro also occur within the vasculature in vivo.
CONCLUSION
As illustrated in this issue of Frontiers, CD44 and HA contribute to
a remarkably diverse spectrum of biologic processes. As leukocyte
adhesion molecules, CD44 and HA display a variety of functional
roles in cell trafficking, and contribute broadly to the initiation,
propagation, and resolution of inflammatory responses. Within
many domains, CD44 and HA are being investigated as potential
therapeutic targets to modulate disease pathology, and leukocyte
recruitment is no exception. Through our expanded knowledge
of the mechanisms regulating CD44 and HA interactions, and
how these influence inflammatory responses, we will gain further
insight into potential therapeutic targets to treat inflammatory
diseases.
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